Cellectis S.A. is 10% Owner at Calyxt, Inc. (CLXT). They have made 1 open-market trade across 1 company since 2018, most recently 2020-10-16.
CIK 0001627281
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.5M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLXT | 23,963,175 | $754.8M |
Shares reported on the most recent Form 4, priced at the 2020-10-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLXT | BUY | 2018-06-15 | 2018-06-15 | $19.49 | $2.5M | -2.3% | -12.2% | -19.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.